Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: BARRY ALLEN who wrote (4110)	1/22/1999 10:27:00 PM
From: Judy Muldawer	Read Replies (1) \| Respond to of 4342

Oh, I just love it when he talks likes this: Friday January 22, 3:46 pm Eastern Time Company Press Release SOURCE: Paracelsian Inc. Paracelsian Chairman and CEO Interviewed by Wall Street Reporter ITHACA, N.Y., Jan. 22 /PRNewswire/ -- Paracelsian Inc. (OTC Bulletin Board: PRLN - news) announced today that Bernie Landes, Chairman, President and CEO was interviewed on January 12, 1999 by the Wall Street Reporter. The entire interview can be heard via the Internet at either Wall Street Reporter's website (http://wallstreetreporter.com) or at Paracelsian's website (http://www.paracelsian.com). The interview will remain available for the remainder of 1999. Mr. Landes reviewed the Company's background and its success over the last year in refocusing its energies to develop substantial revenue streams from its principal assets. Mr. Landes explains in detail how the Company's new focus on its three key business segments...Quality Assurance for herbal products including the BioFIT(TM) Certification program, Environmental Monitoring utilizing the company's Patented screen for Dioxin, and Drug Development taking advantage of the company's extensive library of Traditional Chinese Medicines. ''I believe that this interview signifies a heightened level of interest in Paracelsian and its potential for significant growth and profits in the near future,'' said Mr. Landes. ''I think all interested parties will be pleased to hear just how far we've come and how bright our prospects are for the future,'' he added. Paracelsian is a unique biotechnology company whose business centers on the development and application of functional bioassays. These assays are used for Quality Assurance of herbs, botanicals and other dietary supplements, in the development of dietary supplements, OTC and pharmaceutical products, and in monitoring environmental toxins and identifying carcinogens. Notice: This news release may contain forward-looking statements. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development, commercialization and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. SOURCE: Paracelsian Inc. More Quotes and News: Paracelsian Inc (OTC BB:PRLN - news) Related News Categories: banking, biotech, medical/pharmaceutical